158 related articles for article (PubMed ID: 3319150)
1. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on growth inhibition and regression of cancer metastases].
Chihara G
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1196-209. PubMed ID: 4004287
[TBL] [Abstract][Full Text] [Related]
4. Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses.
Maeda YY; Watanabe ST; Chihara C; Rokutanda M
Cancer Res; 1988 Feb; 48(3):671-5. PubMed ID: 2446749
[TBL] [Abstract][Full Text] [Related]
5. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation and consideration of BRM-BRM and HDP (host defense potentiators)].
Chihara G
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1588-96. PubMed ID: 3382231
[TBL] [Abstract][Full Text] [Related]
8. Current status and perspectives of immunomodulators of microbial origin.
Chihara G; Maeda YY; Hamuro J
Int J Tissue React; 1982; 4(3):207-25. PubMed ID: 6815071
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of lentinan in animal models.
Chihara G
Adv Exp Med Biol; 1983; 166():189-97. PubMed ID: 6606302
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Moriya N; Miwa H; Taketsuka S; Orita K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
[TBL] [Abstract][Full Text] [Related]
11. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides.
Wasser SP
Appl Microbiol Biotechnol; 2002 Nov; 60(3):258-74. PubMed ID: 12436306
[TBL] [Abstract][Full Text] [Related]
12. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
13. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
14. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
[TBL] [Abstract][Full Text] [Related]
15. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
16. [Age-dependent anti-tumor activity of lentinan in mice].
Shiio T; Yoshihama T; Tsuchiya Y; Yugari Y
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2300-4. PubMed ID: 3606149
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
[TBL] [Abstract][Full Text] [Related]
18. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor action of interleukin 2 and its biological activities].
Hamuro J
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2111-8. PubMed ID: 3496854
[TBL] [Abstract][Full Text] [Related]
20. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
